Posts

Showing posts with the label healtcare

Designing the Belgian “To Be” State: Transforming MZG/RHM and Finhosta for Patient-Based Costing, Care-Process Alignment, and DRG Reform

Introduction In Belgium, hospital financing reform should start from the target state to be achieved rather than from the inherited institutional configuration to be incrementally adjusted. That is especially important because the Belgian health system is structurally path-dependent: it combines near-universal compulsory insurance with direct access, predominantly fee-for-service remuneration, and a division of responsibilities between the federal state and the federated entities that was deepened by the sixth State reform. In hospital financing, Belgium already uses All Patient Refined Diagnosis Related Groups (APR-DRG)/Severity of Illness (SOI) information for budget allocation, but not as a true case-based payment system with national cost weights; the current B2 logic of the Budget of Financial Means (BFM) uses national average length of stay by APR-DRG/SOI as a proxy for resource use. At the same time, Belgium has two mandatory hospital datasets with major strategic value: Minima...

European Health Data Space (EHDS) - Potential Benefits & Potential Threats

The European Health Data Space (EHDS) is an ambitious initiative by the European Union to enhance the sharing and use of health data across member states. It aims to improve healthcare delivery, research, and innovation while ensuring strong data protection. An overview of potential benefits and threats associated with the EHDS: Potential Benefits : Improved Healthcare Delivery: Patients and healthcare professionals will have easier access to health records across EU countries, enabling better treatment, especially for cross-border healthcare. Reduces redundant tests and medical errors. Enhanced Research and Innovation: Facilitates large-scale health data access for researchers, allowing faster medical discoveries, AI-driven diagnostics, and drug development. Encourages innovation in personalized medicine. Public Health Improvements: Enables real-time disease surveillance and quicker response to pandemics. Supports policy-making through better data analysis on health trends. Boosts EU’...